MYL9 and neoplasm: The results of Jin et al. (2016) showed that, compared with normal gastric mucosa, myosin light chain 9 (MYL9) was abnormally upregulated in GC patients’ tumor tissues, and it could affect the prognosis of GC patients through adhesion plaque and leukocyte cross-endothelial migration.